Literature DB >> 32915646

Computed tomography appearances of the lung parenchyma in pulmonary hypertension.

Robert W Foley1, Nirav Kaneria2, Rob V MacKenzie Ross2, Jay Suntharalingam2, Benjamin J Hudson1, Jonathan Cl Rodrigues1, Graham Robinson1.   

Abstract

Computed tomography (CT) is a valuable tool in the workup of patients under investigation for pulmonary hypertension (PH) and may be the first test to suggest the diagnosis. CT parenchymal lung changes can help to differentiate the aetiology of PH. CT can demonstrate interstitial lung disease, emphysema associated with chronic obstructive pulmonary disease, features of left heart failure (including interstitial oedema), and changes secondary to miscellaneous conditions such as sarcoidosis. CT also demonstrates parenchymal changes secondary to chronic thromboembolic disease and venous diseases such as pulmonary venous occlusive disease (PVOD) and pulmonary capillary haemangiomatosis (PCH). It is important for the radiologist to be aware of the various manifestations of PH in the lung, to help facilitate an accurate and timely diagnosis. This pictorial review illustrates the parenchymal lung changes that can be seen in the various conditions causing PH.

Entities:  

Mesh:

Year:  2020        PMID: 32915646      PMCID: PMC7774692          DOI: 10.1259/bjr.20200830

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  73 in total

1.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marc Humbert; Jean-Luc Vachiery; Simon Gibbs; Irene Lang; Adam Torbicki; Gérald Simonneau; Andrew Peacock; Anton Vonk Noordegraaf; Maurice Beghetti; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; Georg Hansmann; Walter Klepetko; Patrizio Lancellotti; Marco Matucci; Theresa McDonagh; Luc A Pierard; Pedro T Trindade; Maurizio Zompatori; Marius Hoeper
Journal:  Eur Respir J       Date:  2015-08-29       Impact factor: 16.671

2.  Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.

Authors:  Eric Hachulla; Virginie Gressin; Loïc Guillevin; Patrick Carpentier; Elisabeth Diot; Jean Sibilia; André Kahan; Jean Cabane; Camille Francès; David Launay; Luc Mouthon; Yannick Allanore; Kiet Phong Tiev; Pierre Clerson; Pascal de Groote; Marc Humbert
Journal:  Arthritis Rheum       Date:  2005-12

3.  Pulmonary histiocytosis X: evaluation with high-resolution CT.

Authors:  M W Brauner; P Grenier; M M Mouelhi; D Mompoint; S Lenoir
Journal:  Radiology       Date:  1989-07       Impact factor: 11.105

4.  The CT findings of pulmonary sarcoidosis: analysis of 25 patients.

Authors:  N L Müller; P Kullnig; R R Miller
Journal:  AJR Am J Roentgenol       Date:  1989-06       Impact factor: 3.959

5.  CT-Definable Subtypes of Chronic Obstructive Pulmonary Disease: A Statement of the Fleischner Society.

Authors:  David A Lynch; John H M Austin; James C Hogg; Philippe A Grenier; Hans-Ulrich Kauczor; Alexander A Bankier; R Graham Barr; Thomas V Colby; Jeffrey R Galvin; Pierre Alain Gevenois; Harvey O Coxson; Eric A Hoffman; John D Newell; Massimo Pistolesi; Edwin K Silverman; James D Crapo
Journal:  Radiology       Date:  2015-05-11       Impact factor: 11.105

6.  Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.

Authors:  Motohiro Kimura; Hiroyuki Taniguchi; Yasuhiro Kondoh; Tomoki Kimura; Kensuke Kataoka; Osamu Nishiyama; Hiromichi Aso; Koji Sakamoto; Yoshinori Hasegawa
Journal:  Respiration       Date:  2012-12-19       Impact factor: 3.580

7.  Pulmonary infarction: spectrum of findings on multidetector helical CT.

Authors:  Hongying He; Marjorie W Stein; Benjamin Zalta; Linda B Haramati
Journal:  J Thorac Imaging       Date:  2006-03       Impact factor: 3.000

8.  Automated quantification of pulmonary perfused blood volume by dual-energy CTPA in chronic thromboembolic pulmonary hypertension.

Authors:  F G Meinel; A Graef; K M Thierfelder; M Armbruster; C Schild; C Neurohr; M F Reiser; T R C Johnson
Journal:  Rofo       Date:  2013-08-23

Review 9.  Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2015-06-07       Impact factor: 202.731

10.  Pulmonary hemodynamic profile in chronic obstructive pulmonary disease.

Authors:  Karina Portillo; Yolanda Torralba; Isabel Blanco; Felip Burgos; Roberto Rodriguez-Roisin; Jose Rios; Josep Roca; Joan A Barberà
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-14
View more
  2 in total

1.  Predictive value of chest HRCT for survival in idiopathic pulmonary arterial hypertension.

Authors:  Aneta Kacprzak; Barbara Burakowska; Marcin Kurzyna; Anna Fijałkowska; Michał Florczyk; Maria Wieteska-Miłek; Szymon Darocha; Adam Torbicki; Monika Szturmowicz
Journal:  Respir Res       Date:  2021-11-17

Review 2.  An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients.

Authors:  Barbara Ruaro; Francesco Salton; Elisa Baratella; Paola Confalonieri; Pietro Geri; Riccardo Pozzan; Chiara Torregiani; Roberta Bulla; Marco Confalonieri; Marco Matucci-Cerinic; Michael Hughes
Journal:  Diagnostics (Basel)       Date:  2022-03-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.